| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10658 | 2021 |
| Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, ... Autophagy 4 (2), 151-175, 2008 | 2714 | 2008 |
| Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas JL Teeling, RR French, MS Cragg, J van den Brakel, M Pluyter, H Huang, ... Blood 104 (6), 1793-1800, 2004 | 859 | 2004 |
| Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts MS Cragg, SM Morgan, HTC Chan, BP Morgan, AV Filatov, ... Blood, The Journal of the American Society of Hematology 101 (3), 1045-1052, 2003 | 806 | 2003 |
| Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents MS Cragg, MJ Glennie Blood 103 (7), 2738-2743, 2004 | 735 | 2004 |
| Mechanisms of killing by anti-CD20 monoclonal antibodies MJ Glennie, RR French, MS Cragg, RP Taylor Molecular immunology 44 (16), 3823-3837, 2007 | 661 | 2007 |
| Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain K Askew, K Li, A Olmos-Alonso, F Garcia-Moreno, Y Liang, P Richardson, ... Cell reports 18 (2), 391-405, 2017 | 655 | 2017 |
| The biology of CD20 and its potential as a target for mAb therapy MS Cragg, CA Walshe, AO Ivanov, MJ Glennie B cell trophic factors and B cell antagonism in autoimmune disease 8, 140-174, 2005 | 518 | 2005 |
| Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection SA Beers, RR French, HTC Chan, SH Lim, TC Jarrett, RM Vidal, ... Blood, The Journal of the American Society of Hematology 115 (25), 5191-5201, 2010 | 401 | 2010 |
| Gefitinib-Induced Killing of NSCLC Cell Lines Expressing Mutant EGFR Requires BIM and Can Be Enhanced by BH3 Mimetics MS Cragg, J Kuroda, H Puthalakath, DCS Huang, A Strasser PLoS medicine 4 (10), e316, 2007 | 386 | 2007 |
| Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic J Kuroda, H Puthalakath, MS Cragg, PN Kelly, P Bouillet, DCS Huang, ... Proceedings of the National Academy of Sciences 103 (40), 14907-14912, 2006 | 376 | 2006 |
| Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies W Alduaij, A Ivanov, J Honeychurch, EJ Cheadle, S Potluri, SH Lim, ... Blood, The Journal of the American Society of Hematology 117 (17), 4519-4529, 2011 | 351 | 2011 |
| Anti-CD20 monoclonal antibodies: historical and future perspectives SH Lim, SA Beers, RR French, PWM Johnson, MJ Glennie, MS Cragg haematologica 95 (1), 135, 2010 | 333 | 2010 |
| Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy SH Lim, AT Vaughan, M Ashton-Key, EL Williams, SV Dixon, HTC Chan, ... Blood, The Journal of the American Society of Hematology 118 (9), 2530-2540, 2011 | 292 | 2011 |
| CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts HTC Chan, D Hughes, RR French, AL Tutt, CA Walshe, JL Teeling, ... Cancer research 63 (17), 5480-5489, 2003 | 287 | 2003 |
| CD20 as a target for therapeutic type I and II monoclonal antibodies SA Beers, CHT Chan, RR French, MS Cragg, MJ Glennie Seminars in hematology 47 (2), 107-114, 2010 | 279 | 2010 |
| Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody AL White, HT Chan, A Roghanian, RR French, CI Mockridge, AL Tutt, ... The Journal of Immunology 187 (4), 1754-1763, 2011 | 271 | 2011 |
| Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation SA Beers, CHT Chan, S James, RR French, KE Attfield, CM Brennan, ... Blood, The Journal of the American Society of Hematology 112 (10), 4170-4177, 2008 | 242 | 2008 |
| Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics MS Cragg, C Harris, A Strasser, CL Scott Nature Reviews Cancer 9 (5), 321-326, 2009 | 235 | 2009 |
| Signaling antibodies in cancer therapy MS Cragg, RR French, MJ Glennie Current opinion in immunology 11 (5), 541-547, 1999 | 234 | 1999 |
